FATE THERAPEUTICS INC Share Price
FATE THERAPEUTICS INC (FATE) had Share Price of $2.12 per share as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2023-11-08
- 2023-09-30: Share Price $2.12.
- 2023-06-30: Share Price $4.76.
- 2023-03-31: Share Price $5.70.
- 2022-12-31: Share Price $10.09.
| Period end | Share Price |
|---|---|
| 2023-09-30 | $2.12 10-Q · filed 2023-11-08 |
| 2023-06-30 | $4.76 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.70 10-Q · filed 2023-05-03 |
| 2022-12-31 | $10.09 10-K · filed 2023-02-28 |
| 2022-09-30 | $22.41 10-Q · filed 2022-11-03 |
| 2022-06-30 | $24.78 10-Q · filed 2022-08-03 |
| 2022-03-31 | $38.77 10-Q · filed 2022-05-04 |
| 2021-12-31 | $58.51 10-K · filed 2022-02-28 |
| 2021-09-30 | $59.27 10-Q · filed 2021-11-04 |
| 2021-06-30 | $86.79 10-Q · filed 2021-08-04 |
| 2021-03-31 | $82.45 10-Q · filed 2021-05-05 |
| 2020-12-31 | $90.93 10-K · filed 2021-02-24 |
| 2020-09-30 | $39.97 10-Q · filed 2020-11-05 |
| 2013-12-31 | $13.00 10-K · filed 2014-03-17 |
| 2013-10-04 | $6.00 10-Q · filed 2015-05-07 |
| 2012-12-31 | $21.00 10-K · filed 2014-03-17 |
| 2010-12-31 | $5.00 10-K · filed 2014-03-17 |
| 2009-12-31 | $17.00 10-K · filed 2014-03-17 |
| 2008-12-31 | $1.00 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |